1
|
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
J Natl Cancer Inst
|
2012
|
1.99
|
2
|
Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions.
|
Int J Cancer
|
2002
|
1.64
|
3
|
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.
|
Proc Natl Acad Sci U S A
|
2010
|
1.27
|
4
|
Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma.
|
Br J Haematol
|
2005
|
0.94
|
5
|
Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated.
|
Int J Cancer
|
2003
|
0.92
|
6
|
SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.
|
Leuk Res
|
2010
|
0.88
|
7
|
Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma.
|
Br J Haematol
|
2005
|
0.86
|
8
|
Classical Hodgkin lymphoma is associated with frequent gains of 17q.
|
Genes Chromosomes Cancer
|
2003
|
0.86
|
9
|
The retrovirus XMRV is not directly involved in the pathogenesis of common types of lymphoid malignancy.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.80
|